NovaBridge Biosciences (NBP) Assets Average (2020 - 2026)

NovaBridge Biosciences (NBP) has reported Assets Average for 6 consecutive years, with $269.0 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Assets Average rose 20.79% year-over-year to $269.0 million; the TTM figure through Dec 2025 stood at $269.0 million (up 20.79% YoY), while the FY2025 annual figure was $236.6 million, down 18.66% from the prior year.
• Assets Average improved to $269.0 million in Q4 2025 per NBP's latest filing, from $242.1 million in the prior quarter.
• Across five years, Assets Average topped out at $954.0 million in Q2 2021 and bottomed at $207.8 million in Q2 2025.
• Historically, Assets Average has averaged $478.4 million across 5 years, with a median of $269.0 million in 2025.
• Annual changes were most pronounced in 2021 — Assets Average soared 255.62% — and 2023, when it sank 34.8%.
• NovaBridge Biosciences' Assets Average stood at $914.1 million in 2021, then decreased by 27.91% to $659.0 million in 2022, then slipped by 19.8% to $528.5 million in 2023, then slumped by 57.87% to $222.7 million in 2024, then increased by 20.79% to $269.0 million in 2025.
• Business Quant data shows NBP's Assets Average at $269.0 million in Q4 2025, $242.1 million in Q3 2025, and $207.8 million in Q2 2025.